Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now

The article recommends AbbVie (ABBV), Lockheed Martin (LMT), and PayPal (PYPL) as undervalued growth stocks for long-term investors. AbbVie is highlighted for its diverse healthcare portfolio, robust revenue growth (8% YTD to $44.5B), and a forward P/E under 17, alongside a 3.3% dividend yield. Lockheed Martin is positioned to benefit from increased defense spending, trading at a forward P/E of 17 with a 2.8% dividend. PayPal, the cheapest with a forward P/E of 12, is noted for its strong brand, nearly 5% revenue growth to $24.5B, 25% net income growth, and new growth opportunities like its integration with OpenAI's ChatGPT.

Analysis

The article highlights AbbVie, Lockheed Martin, and PayPal as undervalued growth stocks for long-term investment, underpinned by attractive forward valuations and distinct growth drivers. The overall sentiment is strongly positive, suggesting potential for significant capital appreciation.

AbbVie demonstrates a compelling forward P/E under 17, contrasting with a high trailing P/E, supported by 8% year-to-date revenue growth to $44.5 billion and a robust 3.3% dividend yield. Its diverse healthcare portfolio, particularly 12% growth in immunology drugs, positions it for continued expansion. Lockheed Martin, also at a forward P/E of 17, is poised to benefit from anticipated increases in U.S. defense spending, having reported 4% sales growth to $54.7 billion and offering a 2.8% dividend.

PayPal emerges as the most attractively valued with a forward P/E of 12 and a PEG ratio below 1, driven by 5% revenue growth to $24.5 billion and a 25% increase in net income. Its strategic integration with OpenAI's ChatGPT provides a significant new growth opportunity, enhancing its established brand and recent dividend initiation. These companies collectively offer diversified exposure across healthcare, defense, and fintech, supported by strong fundamental metrics and shareholder returns.

Key Decisions for Investors

• Investors should consider initiating or increasing long-term positions in AbbVie, Lockheed Martin, and PayPal, given their identified undervaluation and specific growth catalysts.
• Monitor AbbVie's pipeline diversification and immunology segment performance, alongside Lockheed Martin's sales trajectory in response to evolving defense budgets.
• Assess PayPal's execution on its OpenAI ChatGPT integration and its ability to sustain net income growth as key performance indicators.
• Factor in the attractive dividend yields from AbbVie (3.3%) and Lockheed Martin (2.8%) as a component of total return for income-oriented portfolios.